Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical rapamycin with or without pulsed dye laser for capillary malformations in Sturge-Weber syndrome
2010-024078-20Phase 2Completed
- Sponsor
- Cima Universidad de Navarra
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of sirolimus in Sturge-Weber syndrome (SWS) and port-wine stain (4 arms), sponsored by Cima Universidad de Navarra. Primary endpoints: Lesion area reduction, Reduction in red/pink coloration and 3 more. Started Dec 2010; status: completed.
02
Drugs
sirolimus
03
Conditions
Sturge-Weber syndrome (SWS)port-wine stain
Beyond the preview
Go deeper on 2010-024078-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024078-20.